Biology of Reproduction, Vol 56, 757-763, Copyright © 1997 by Society for the Study of Reproduction

ARTICLES

Potent blood coagulant activity of human semen due to prostasome-bound tissue factor

JA Fernandez, MJ Heeb, KP Radtke and JH Griffin
Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, California 92037, USA.

Human semen contains very potent blood clotting activity; for example, seminal serum diluted up to 10,000-fold significantly decreased the recalcification clotting time of blood plasma. This seminal coagulant activity was dependent on factor X and calcium ions, suggesting the presence of a facto X activator. Immunoblotting analysis and immunoadsorption studies confirmed the presence of tissue factor antigen (45 kDa) in semen. Centrifugation studies suggested that tissue factor was membrane associated, and fractionation of seminal serum by gel filtration followed by immunoelectron microscopy revealed that tissue factor antigen was on the prostasome vesicle surface. Tissue factor originated from prostatic fluid and not from seminal vesicle secretions. Tissue factor antigen averaged 21 ng/ml in seminal serum. Hypothetical roles for very high levels of tissue factor in semen include several possibilities. In the event of abrasion and bleeding during intercourse, rapid blood clotting at lesion sites would prevent sperm and seminal components, including infectious agents such as human immunodeficiency virus, from entering the blood stream, generating antibodies, or promoting infectious disease. This could imply that development of infection from semen-borne agents or development of antisperm antibodies in some patients could result from impairment or absence of seminal tissue factor.

This article has been cited by other articles:

				H.P. Burden, C.H. Holmes, R. Persad, and K. Whittington Prostasomes--their effects on human male reproduction and fertility Hum. Reprod. Update, May 1, 2006; 12(3): 283 - 292. [Abstract] [Full Text] [PDF]

				B. A. Lwaleed, R. S. Greenfield, J. Hicks, B. R. Birch, and A. J. Cooper Quantitation of Seminal Factor IX and Factor IXa in Fertile, Nonfertile, and Vasectomy Subjects: A Step Closer Toward Identifying a Functional Clotting System in Human Semen J Androl, January 1, 2005; 26(1): 146 - 152. [Abstract] [Full Text] [PDF]

				D. Floryk, S. L. Tollaksen, C. S. Giometti, and E. Huberman Differentiation of Human Prostate Cancer PC-3 Cells Induced by Inhibitors of Inosine 5'-Monophosphate Dehydrogenase Cancer Res., December 15, 2004; 64(24): 9049 - 9056. [Abstract] [Full Text] [PDF]

				F. Saez, G. Frenette, and R. Sullivan Epididymosomes and Prostasomes: Their Roles in Posttesticular Maturation of the Sperm Cells J Androl, March 1, 2003; 24(2): 149 - 154. [Full Text] [PDF]

				P. Ek, J. Malm, H. Lilja, L. Carlsson, and G. Ronquist Exogenous Protein Kinases A and C, But Not Endogenous Prostasome-Associated Protein Kinase, Phosphorylate Semenogelins I and II From Human Semen J Androl, November 1, 2002; 23(6): 806 - 814. [Abstract] [Full Text] [PDF]

				E. Andersson, O.E. Sorensen, B. Frohm, N. Borregaard, A. Egesten, and J. Malm Isolation of human cationic antimicrobial protein-18 from seminal plasma and its association with prostasomes Hum. Reprod., October 1, 2002; 17(10): 2529 - 2534. [Abstract] [Full Text] [PDF]